1. Dejkhamron P, Menon RK, Sperling MA. Childhood diabetes mellitus: recent advances & future prospects. Indian J Med Res. 2007; 125:231–250.
2. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care. 1997; 20:1183–1197.
3. Sperling MA. Diabetes Mellitus. In : Sperling MA, editor. Pediatric endocrinology. 2nd ed. Philadelphia: Saunders;2002. p. 323–366.
4. Aanstoot HJ, Anderson BJ, Daneman D, Danne T, Donaghue K, Kaufman F, et al. The global burden of youth diabetes: perspectives and potential. Pediatr Diabetes. 2007; 8:Suppl 8. 1–44.
5. Devendra D, Liu E, Eisenbarth GS. Type 1 diabetes: recent developments. BMJ. 2004; 328:750–754.
Article
6. Ize-Ludlow D, Sperling MA. The classification of diabetes mellitus: a conceptual framework. Pediatr Clin North Am. 2005; 52:1533–1552.
Article
7. Reinehr T. Type 2 diabetes mellitus in children and adolescents. World J Diabetes. 2013; 4:270–281.
Article
8. Arslanian S. Type 2 diabetes in children: clinical aspects and risk factors. Horm Res. 2002; 57:Suppl 1. 19–28.
Article
9. Craig ME, Hattersley A, Donaghue KC. Definition, epidemiology and classification of diabetes in children and adolescents. Pediatr Diabetes. 2009; 10:Suppl 12. 3–12.
Article
10. Barrett TG. Non autoimmune forms of diabetes: Neonatal diabetes, DIDMOAAD-Wolfram, and related syndromes. In : Sperling MA, editor. Type 1 Diabetes. Totowa: Humana Press;2003. p. 163–182.
11. Porter JR, Barrett TG. Acquired non-type 1 diabetes in childhood: subtypes, diagnosis, and management. Arch Dis Child. 2004; 89:1138–1144.
Article
12. Samuelsson U, Stenhammar L. Clinical characteristics at onset of Type 1 diabetes in children diagnosed between 1977 and 2001 in the south-east region of Sweden. Diabetes Res Clin Pract. 2005; 68:49–55.
Article
13. Hekkala A, Knip M, Veijola R. Ketoacidosis at diagnosis of type 1 diabetes in children in northern Finland: temporal changes over 20 years. Diabetes Care. 2007; 30:861–866.
Article
14. Morimoto A, Nishimura R, Tajima N. Trends in the epidemiology of patients with diabetes in Japan. JMAJ. 2010; 53:36–40.
15. Lee CW, Shin HJ, Kim DH. Prevalence of autoimmune antibodies in type i diabetic children and their siblings. J Korean Soc Pediatr Endocrinol. 1999; 4:78–87.
16. Hong EH, Park JS, Lee HS, Cho MH, Ko CW. Clinical characteristics and laboratory findings of children who were newly diagnosed with diabetes mellitus (From 2001 to 2008). J Korean Soc Pediatr Endocrinol. 2009; 14:110–115.
17. Yu J, Shin CH, Yang SW, Park MH, Eisenbarth GS. Analysis of children with type 1 diabetes in Korea: high prevalence of specific anti-islet autoantibodies, immunogenetic similarities to Western populations with "unique" haplotypes, and lack of discrimination by aspartic acid at position 57 of DQB. Clin Immunol. 2004; 113:318–325.
Article
18. Klingensmith GJ, Pyle L, Arslanian S, Copeland KC, Cuttler L, Kaufman F, et al. The presence of GAD and IA-2 antibodies in youth with a type 2 diabetes phenotype: results from the TODAY study. Diabetes Care. 2010; 33:1970–1975.
Article
19. Kong YH, Kim MS, Lee DY. Comparison of the prevalence of islet autoantibodies according to age and disease duration in patients with type 1 diabetes mellitus. Ann Pediatr Endocrinol Metab. 2013; 18:65–70.
Article
20. Katz LE, Jawad AF, Ganesh J, Abraham M, Murphy K, Lipman TH. Fasting c-peptide and insulin-like growth factor-binding protein-1 levels help to distinguish childhood type 1 and type 2 diabetes at diagnosis. Pediatr Diabetes. 2007; 8:53–59.
Article
21. Cho MJ, Kim MS, Kim CJ, Kim EY, Kim JD, Kim EY, et al. Fasting serum C-peptide is useful for initial classification of diabetes mellitus in children and adolescents. Ann Pediatr Endocrinol Metab. 2014; 19:80–85.
Article
22. Besser RE. Determination of C-peptide in children: when is it useful. Pediatr Endocrinol Rev. 2013; 10:494–502.
23. Jones AG, Hattersley AT. The clinical utility of C-peptide measurement in the care of patients with diabetes. Diabet Med. 2013; 30:803–817.
Article